Rubin Jonathan 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Rubin Jonathan（CIK 1836067）在 1 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-08-14）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-14 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 买入 | 750 | $0 |
| 2026-08-14 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 卖出 | 363 | $16,905 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 买入 | 1,250 | $0 |
| 2026-02-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 卖出 | 675 | $34,216 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 买入 | 1,125 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 卖出 | 603 | $30,964 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 买入 | 750 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 卖出 | 369 | $18,767 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 买入 | 1,250 | $0 |
| 2026-02-25 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 卖出 | 671 | $0 |
| 2025-09-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 买入 | 1,875 | $0 |
| 2025-09-26 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | SVP, Chief Medical Officer | 卖出 | 840 | $38,816 |
来源：SEC Form 4 申报文件 · 截至 2026-08-14